Description
N/A
In-Apps
- 季度VIP
- 119.90 S/
- 年度VIP
- 499.90 S/
- 月度VIP
- 59.90 S/
- 季度SVIP
- 119.90 S/
- 年度SVIP
- 499.90 S/
- 月度SVIP
- 59.90 S/
Screenshots
Loading...
Please wait..
全球医 FAQ
-
Is 全球医 free?
Yes, 全球医 is free to download, however it contains in-app purchases or subscription offerings.
-
Is 全球医 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 全球医 cost?
全球医 has several in-app purchases/subscriptions, the average in-app price is 226.57 S/.
-
What is 全球医 revenue?
To get estimated revenue of 全球医 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Peru yet.
Ratings History
全球医 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
全球医 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
医通宝
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
海心健康-肿瘤全病程管理与服务平台
癌症问诊交流和医疗服务平台
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
癌度-癌友圈互帮互助知识社区
结识病情相似的癌友，互帮互助共同康复
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
易加医-肿瘤就医新药搜寻专家预约
肿瘤求医问药服务专家
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
肿瘤化疗助手
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
找药宝典
肿瘤患者康复交流互助平台
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
达摩健康~~跨境医疗一站式平台
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
伙伴医生
最值得信赖的健康医疗服务平台
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
肿瘤前沿
|
Unlock
|
Unlock
|
0
|
|
4 years ago | |
康爱公社-大病互助平台开创者(原名抗癌公社)
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
全球医 Installs
Last 30 days
全球医 Revenue
Last 30 days全球医 Revenue and Downloads
Gain valuable insights into 全球医 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 上海宙赛网络科技有限公司
- Languages
- Chinese
- Recent release
- 2.1.0 (4 years ago )
- Released on
- Feb 26, 2020 (4 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.